Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 1301-1309

  Matsumoto, Masayuki ^a   Hsieh, Tsai Yuan ^a   Zhu, Nongliao ^a   Van Arsdale, Todd ^b   Hwang, Soon B ^a   Jeng, King Song ^a   Gorbalenya, Alexander E ^c,d   Lo, Shi Yen ^a   Ou, Jing Hsiung ^a   Ware, Carl F ^b   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CYTOPLASM; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; RECEPTOR BINDING; VIRUS PATHOGENESIS;

EID: 18844480671     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.1301-1309.1997     Document Type: Article

References (63)

1. Aach, R. D., C. E. Stevens, F. B. Hollinger, J.W. Mosley,D. A. Peterson, P. E. Taylor, R. G. Johnson, L. H. Barbosa, and G. J. Nemo. 1991. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N. Engl. J. Med. 325:1325-1329.
2. Agnello, V., R. T. Chung, and L. M. Kaplan. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327:1490-1495.
3. Almasio, P., G. Provenzano, M. Scimemi, G. Cascio, A. Craxi, and L. Pagliaro. 1992. Hepatitis C virus and Sjogren's syndrome. Lancet 339:989-990.
4. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P.-Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner et al. 1992. The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327:1899-1905.
5. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
6. Browning, J. L., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. MacKay. 1996. Signaling through the lymphotoxin βreceptor induces the death of some adenoearcinoma tumor lines. J. Exp. Med. 183:867-878.
7. Chang, M.-F., S. C. Baker, L. H. Soe, T. Kamahora, J. G. Keck, S. Makino, S. Govindarajan, and M. M. C. Lai. 1988. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-hinding activity. J. Virol. 62:2403-2410.
8. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
9. Chen, P.-J., M.-H. Lin, K.-F. Tai, P.-C. Liu, C.-J. Lin, and D.-S. Chen. 1992. The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA. Virology 188: 102-113.
10. Chien, C-T., P. L. Bartel, R. Sternglanz, and S. Fields. 1991. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA 88:9578-9582.
11. Chien, D. Y., Q.-L. Choo, R. Ralston, R. Spaete, M. Tong, M. Houghton, and G. Kuo. 1993. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933.
12. Choo, Q.-L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, A. Medina-Selby, P. J. Barr, A. J. Weiner, D. W. Bradley, and M. Houghton. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
13. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707-710.
14. Dayhoff, M. O., R. M. Schwartz, and B. C. Orcutt. 1978. Atlas of protein sequence and structure. National Biomedical Research Foundation. Washington, D.C.
15. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fiek, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Sehoenberger, J. H. Russel, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
16. Di Bisceglie, A. M., L. H. Simpson, M. T. Lotze, and J. H. Hoofnagle. 1994. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J. Clin. Gastroenterol. 19:222-226.
17. Enami, M., and K. Enami. 1996. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 70:6653-6657.
18. Force, W. R., B. N. Walker, C. Hession, R. Tizard, C. A. Kozak, J. L. Browning, and C. F. Ware. 1995. Mouse lymphotoxin-β receptor: molecular genetics, ligand binding, and expression. J. lmmunol. 155:5280-5288.
19. Gietz, D., A. St. Jean, R. A. Woods, and R. H. Schiestl. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20:1425.
20. Gluzman, Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175-182.
21. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
22. Grakoui, A., C. Wychowski, C. Lin, S. M. Feinstone, and C. M. Rice. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1385-1395.
23. Haddad, J., P. Deny, C. Munz-Gotheil, J. C. Ambrosini, J. C. Trinchet, D. Paterson, F. Mal, P. Callard, and M. Beaugrand. 1992. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323.
24. Henikoff, S., and J. G. Henikoff. 1992. Amino acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. USA 89:10915-10919.
25. Higgins, D. G., A. J. Bleasby, and R. Fuchs. 1992. CLUSTAL V: improved software for multiple sequence alignment. Comput. Appl. Biosci. 8:189-191.
26. Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, and K. Shimotohno. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA 88:5547-5551.
27. Hwang, S. B., C. Z. Lee, and M. M. C. Lai. 1992. Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms. Virology 190:413-422.
28. Hwang, S. B., S.-Y. Lo, J.-H. Ou, and M. M. C. Lai. 1995. Detection of cellular proteins and viral core protein interacting with the 5′-untranslated region of hepatitis C virus RNA. J. Biomed. Sci. 2:227-236.
29. Johnson, R. J., D. R. Gretch, H. Yamabe, J. Hart, C. E. Bacchi, P. Hartwell, W. G. Couser, L. Corey, M. H. Wener, C. E. Alpers, and R. Willson. 1993. Mcmbrano-proliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med. 328:465-470.
30. Kato, N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA 87:9524-9528.
31. Kato, N., Y. Ootsuyama, H. Sekiya, S. Ohkoshi, T. Nakazawa, M. Hijikata, and K. Shimotohno. 1994. Genetic drift in hypervariablc region 1 of the viral genome in persistent hepatitis C virus infection. J. Virol. 68:4776-4784.
32. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Nomura, H. Miura, I. Nakamura, Y. Yazaki. and M. Imawari. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039-1044.
33. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Gibo, K. Yoshizawa, Y. Nakano, S. Furuta, Y. Akahane, K. Nishioka, R. H. Purcell, and H. J. Alter. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
34. Koziel, M. J., D. Dudley, N. Afdhal, Q.-L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
35. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
36. Lanford, R. E., L. Notvall, D. Chavez, R. White, G. Frenzel, C. Simonsen, and J. Kim. 1993. Analysis of hepatitis C virus capsid, El, and E2/NS1 proteins expressed in insect cells. Virology 197:225-235.
37. Leontovich, A. M., L. I. Brodsky, and A. E. Gorbalenya. 1993. Construction of the full local similarity map for two biopolymers. Biosystems 30:57-63.
38. Lo, S.-Y., F. Masiarz, S. B. Hwang, M. M. C. Lai, and J.-H. Ou. 1995. Differential subcellular localization of hepatitis C virus core gene products. Virology 213:455-461.
39. Lo, S.-Y., M. Selby, M. Tong, and J.-H. Ou. 1994. Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology 199:124-131.
40. Martin. G. A., D. Viskochil, G. Bollag, P. C. McCabe, W. J. Crosier, H. Haubruck, L. Conroy, R. Clark, P. O'Connell, R. M. Cawthon, M. A. Innis, and F. McCormick. 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843-849.
41. Matsumoto, M., S. B. Hwang, K.-S. Jeng, N. Zhu, and M. M. C. Lai. 1996. Homotypic interaction and multimerization of hepatitis C virus core protein. Virolog 218:43-51.
42. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal cancers. Science 271:1289-1291.
43. McFadden, G. 1995. Viroceptors, virokines and related immune modulators encoded by DNA viruses. R. G. Landes Co., Austin. Tex.
44. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-339
45. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L.-Y. Jan, Y.-N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
46. Ray, R. B., L. M. Lagging, K. Meyer, and R. Ray. 1996. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:4438-4443.
47. Ray, R. B., L. M. Lagging, K. Meyer, R. Steele, and R. Ray. 1995. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:209-220.
48. Resnick, R. H., and R. Koff. 1993. Hepatitis C-related hepatocellular carcinoma: prevalence and significance. Arch. Intern. Med. 153:1672-1677.
49. Rost, B., and C. Sander. 1993. Prediction of protein secondary structure at better than 70% accuracy. J. Mol. Biol. 232:584-599.
50. Rathe, M., V. Sarma, V. M. Dixit, and D. V. Doeddel. 1995. TRAF2-mediated activation of NF-ΚB by TNF receptor 2 and DC40. Science 269:1424-1427.
51. Sanderson, C. M., H.-H. Wu, and D. P. Nayak. 1994. Sendai virus M protein binds independent to either the F or the HN glycoprotein in vivo. J. Virol. 68:69-76.
52. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
53. Santolini, E., G. Migliaccio, and N. La Monica. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68: 3631-3641.
54. Shih, C.-M., C.-M. Chen, S.-Y. Chen, and Y.-H. W. Lee. 1995. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 69:1160-1171.
55. Shih, C.-M., S. J. Lo, T. Miyamura, S.-Y. Chen, and Y.-H. W. Lee. 1993. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67:5823-5832.
56. Shirai, M., H. Okada, M. Nishioka, T. Akatsuka, C. Wychowski, R. Houghton, C. D. Pendleton, S. M. Feinstone, and J. A. Berzotsky. 1994. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:3334-3342.
57. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959-962.
58. Sturrock, S. S., and J. F. Collins. 1993. MPsrch version 1.3. Biocomputing Research Unit, University of Edinburgh, Edinburgh, United Kingdom.
59. Tassapoulos, N. C., A. Hatzakis, I. Delladetsima, M. G. Koutelou, A. Todoulos, and V. Miriagou. 1992. Role of hepatitis C virus in acute, non-A, non-B hepatitis in Greece: a 5-year prospective study. Gastroenterology 102:969-972.
60. Tran, A., J.-F. Quaranta, S. Benzaken, V. Thiers, H. T. Chau, P. Hastier, D. Regnier, G. Dreyfus, C. Pradier, J.-L. Sadoul, X. Hebutern, and P. Rampai. 1992. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before Interferon therapy. Hepatology 18:253-257.
61. Tremolada, F., C. tasarin, A. Tagger, M. L. Ribero, G. Realdi, A. Alberti, and A. Ruol. 1991. Antibody to hepatitis C virus in post-transfusion hepatitis. Ann. Intern. Med. 114:277-281.
62. Ware, C. T., T. L. VanArsdale, P. D. Crowe, and J. L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. lmmunol. 198:175-218.
63. Weiner, A., A. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755-2759.